Uncover the Surprising Link Between Pancreatic Cancers and RCC Metastasis: A Deep Dive into the 'Seed and Soil' Hypothesis
Are pancreatic cancers always a dire prognosis? Not always, according to a recent study by Miguel Bronchud, Co-Founder and Advisory Board at Regenerative Medicine Solutions.
Bronchud's LinkedIn post (https://www.linkedin.com/feed/update/urn:li:activity:7394671179963281408/) delves into the intriguing case of renal cell carcinoma (RCC) metastasis to the pancreas, which paradoxically presents a more 'indolent' clinical course. But what's the science behind this phenomenon?
The 'seed and soil' hypothesis, first proposed by Dr. Stephen Paget in 1889, suggests that successful tumor colonization of distant organs relies on a complex interplay between tumor cells and the host organ's microenvironment. This hypothesis has been further explored by Nirmish Singla, from the Departments of Urology and Oncology at The Johns Hopkins University School of Medicine, in a recent review (https://ascopubs.org/doi/10.1200/PO-25-00843).
One of the key players in this process is the transforming growth factor β (TGF-β) and RAS signaling pathway. Joan Massague, a pharmacologist with extensive experience in New York, has recently published that EMT (epithelial-to-mesenchymal transition) and ECM (extracellular matrix) remodeling are crucial processes during carcinoma invasion and metastasis. These processes are triggered by TGF-β and RAS, which jointly activate the expression of EMT and fibrogenic factors in carcinoma cells.
In their research, Massague and his team discovered that these two processes work together to create a program for lung adenocarcinoma metastasis. They identified chromatin determinants that link the expression of specific genes to TGF-β and RAS inputs, allowing them to prime enhancers for activation by a SMAD4-INO80 nucleosome remodeling complex in response to TGF-β.
This discovery has important implications for understanding the metastatic organotropism of RCC. RCC's unique ability to metastasize to nearly any site in the body makes it an interesting model for studying this process. Moreover, patients with RCC metastatic to the pancreas exhibit an often non-aggressive clinical course, which is an intriguing paradox.
But here's where it gets controversial... The molecular mechanisms behind this phenomenon are still not fully understood. While the 'seed and soil' hypothesis provides a framework for understanding metastatic dissemination, the specific interactions between RCC cells and the pancreatic microenvironment remain a mystery. This opens up a fascinating area for further research and discussion.
So, what do you think? Do you agree with the 'seed and soil' hypothesis? Or do you have a different interpretation of the molecular mechanisms behind RCC metastasis to the pancreas? Share your thoughts in the comments below!
